» Articles » PMID: 36765401

The Members of the MiR-148/152 Family Inhibit Cancer Stem Cell-like Properties in Gastric Cancer Via Negative Regulation of ITGA5

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Feb 11
PMID 36765401
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The role of microRNA (miRNA) in modulating the function of cancer stem cells through diverse signaling pathway has been evidenced. We here identified a role of microRNA (miRNA) family, specifically miR-148/152, in gastric cancer and delineated its functional effects on gastric cancer stem cells.

Methods: Bioinformatics analysis was conducted to analyze expression of integrin α5 (ITGA5) which was verified through expression determination in clinical tissue samples. Next, the upstream regulatory factors of ITGA5 were determined. CD44EpCAM (high) cells sorted from AGS cells subjected to gain-of-function experiments, followed by evaluation of their capacity of colony formation, generation of tumorosphere, cell migration and viability in vitro and xenograft tumor formation in vivo.

Results: ITGA5 was elevated in gastric cancer tissues and confirmed as a target gene of the miR-148/152 family members. The miR-148/152 family members were downregulated in gastric cancer tissues and cells. Decreased expression of miR-148/152 family members was also detected in gastric cancer stem cells. However, the raised expression led to reduced colony formation, tumorosphere, cell migration, cell viability, and drug resistance of CD44+EpCAM (high) AGS cells in vitro, and tumorigenesis in vitro. ITGA5 overexpression reversed the effect of the miR-148/152 family members.

Conclusions: This study demonstrates that the miR-148/152 family members may prevent gastric cancer stem cell-like properties by targeting ITGA5, which can serve as an appealing target for gastric cancer treatment.

Citing Articles

Myofibroblast-derived extracellular vesicles facilitate cancer stemness of hepatocellular carcinoma via transferring ITGA5 to tumor cells.

Xiao Y, Tao P, Zhang K, Chen L, Lv J, Chen Z Mol Cancer. 2024; 23(1):262.

PMID: 39574133 PMC: 11580229. DOI: 10.1186/s12943-024-02170-0.


Integrins in cancer stem cells.

Gou S, Wu A, Luo Z Front Cell Dev Biol. 2024; 12:1434378.

PMID: 39239559 PMC: 11375753. DOI: 10.3389/fcell.2024.1434378.


Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy.

Vaxevanis C, Bachmann M, Seliger B J Immunother Cancer. 2024; 12(8).

PMID: 39209767 PMC: 11367391. DOI: 10.1136/jitc-2024-009774.


Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review).

Zhang C, Liang S, Zhang H, Wang R, Qiao H Oncol Rep. 2023; 51(2).

PMID: 38131215 PMC: 10777459. DOI: 10.3892/or.2023.8687.

References
1.
Li Y, Li D, Zhao M, Huang S, Zhang Q, Lin H . Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells. Life Sci. 2018; 208:295-304. DOI: 10.1016/j.lfs.2018.07.032. View

2.
Li L, Chen Y, Li S, Huang C, Qin Y . Expression of miR-148/152 family as potential biomarkers in non-small-cell lung cancer. Med Sci Monit. 2015; 21:1155-61. PMC: 4418282. DOI: 10.12659/MSM.892940. View

3.
Zhu J, Wang F, Wang H, Dong N, Zhu X, Wu Y . TNF-α mRNA is negatively regulated by microRNA-181a-5p in maturation of dendritic cells induced by high mobility group box-1 protein. Sci Rep. 2017; 7(1):12239. PMC: 5612954. DOI: 10.1038/s41598-017-12492-3. View

4.
Ding X, Liu J, Liu T, Ma Z, Wen D, Zhu J . miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. Cancer Med. 2017; 6(6):1301-1310. PMC: 5463086. DOI: 10.1002/cam4.1008. View

5.
Irmak-Yazicioglu M . Mechanisms of MicroRNA Deregulation and MicroRNA Targets in Gastric Cancer. Oncol Res Treat. 2016; 39(3):136-9. DOI: 10.1159/000443224. View